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INTRODUCTION
To date, several methods have been applied to enhance the postoperative healing process and decrease inflammation. [1] [2] [3] Considering the local release of growth factors, platelets can be used as an adjunct to stimulate the regenerative capacity of periosteum and enhance bone healing, especially in postextraction cases. [4] [5] [6] [7] Blood vessels provide the necessary growth factors and inhibitors to initiate the osteogenic biomineralization cascade. Inevitable injury to blood vessels during oral surgical procedures causes blood extravasation and subsequent platelet aggregation and fibrin clot formation. Platelet activation results in formation of blood clots and platelet plugs and subsequent secretion of bioactive proteins, necessary for tissue regeneration and repair. [2, 6, 8] Considering the bioactive properties of platelets in the healing process, they can be used as a valuable therapeutic adjunct in medicine and dentistry. [9, 10] Platelet-rich plasma (PRP) and leukocyte platelet-rich fibrin (LPRF) are the two main autologous products derived from platelets. [11] [12] [13] [14] [15] Many studies have investigated the potential biological differences between these two platelet concentrates. [15, 16] Although they are both clinically effective in accelerating the healing process, platelet-rich fibrin (PRF) is low cost and easy to use and may be added to other bone substitutes. [17] Compared to PRP, LPRF and PRF have demonstrated more sustained release of growth factors from the fine and flexible fibrin matrix in their structure. [15, 18] Furthermore, the presence of high concentrations of leukocytes in LPRF compared to PRF plays a significant role in enhanced release of some crucial growth factors such as transforming growth factor-beta 1. [19] Resorptive remodeling of the alveolar ridge commonly occurs following tooth extraction. This process may be beneficial in fixed orthodontic treatment of patients with severe crowding. [20] [21] [22] Literature is rich with studies on the application of various bioactive grafts to increase the bone maturation rate and enhance the rate of orthodontic tooth movement (OTM). [23] Adequate volume of alveolar bone is a prerequisite for successful OTM during space closure. However, application of different graft materials may enhance the bone filling process and consequently shorten the "regional acceleratory phenomenon" cascade, which includes the release of various growth factors after tooth extraction. LPRF contains concentrated growth factors such as platelet-derived growth factor, transforming growth factor-beta, and insulin-like growth factor 1, which enriches the blood clot formed in the extraction socket and subsequently enhances wound healing and bone regeneration with no inhibitory effect on the natural healing process. [19, 20, 23] Regarding the acceleration of tooth movement, limited publications are available on the efficacy of submucosal injection of PRP to accelerate OTM and preserve the bone. [24] [25] [26] Considering the simultaneous positive effect of PRP/LPRF on bone healing, socket preservation, and acceleration of tooth movement, the current study tested the application of LPRF in tooth extraction sockets to evaluate its efficacy for acceleration of space closure phase of orthodontic treatment. This study sought to evaluate whether LPRF application can accelerate OTM. To the best of our knowledge, this is the first study on the efficacy of LPRF for acceleration of OTM.
MATERIALS AND METHODS

Study design
This split-mouth clinical trial evaluated the efficacy of application of LPRF in extraction sockets for acceleration of OTM in fixed orthodontic patients. A split-mouth design was used to limit the effect of interpersonal variations on response to LPRF. The study was conducted in the Department of Orthodontics and Dentofacial Orthopedics of Shahid Beheshti University of Medical Sciences between March 2015 and March 2016. This clinical trial was registered in www.irct.ir (IRCT2015100724405N1) and followed the CONSORT statement as a guide for study design. Ethical approval was also obtained from the Ethics Committee of Dental Research Center at Shahid Beheshti University of Medical Sciences (protocol approval number: 9310).
Sample size calculation
Sample size was calculated to be thirty extraction sockets (n = 15 in each group) assuming the mean difference and standard deviation (SD) of 0.95, type 1 error (α) of 0.05 and type 2 error (β) of 0.1 to achieve a statistical power of 90% using N = (Z 1 − α/2 + Z 1 − β) 2 × σ 2 /(∆µ) 2 with assumptions of α (significance level) = 0.05 ≥ Z 1 − α/2 = 1.96, β = 0.1 (statistical power = 0.9) ≥Z 1 − β = 1.28, σ = 0.95, ∆µ = 0.95.
Key words: Leukocyte platelet rich fibrin, orthodontic tooth movement, plasma, platelet concentrate, platelet-rich fibrin, platelet-rich plasma Participants and randomization Participants were selected from patients referred to the Department of Orthodontics and Dentofacial Orthopedics at Shahid Beheshti University of Medical Sciences. Male and female orthodontic patients 12 years and older with extraction treatment plan who met the following inclusion criteria were included presence of all maxillary and mandibular permanent teeth except for third molars, comprehensive orthodontic treatment plan of bilateral symmetric extraction of premolar teeth, no medication intake or systemic disease, and full banding/bonding of teeth in both arches. The exclusion criteria were pregnancy, history of previous orthodontic treatment, nonextraction treatment plan, syndromic patients, systemic diseases, or medication intake such as nonsteroidal anti-inflammatory drugs, which would interfere with OTM and history of previous orthodontic treatment. Each patient signed an informed consent form after receiving a thorough explanation regarding the study. In each jaw, the LPRF application quadrant was chosen by drawing lot, done by the corresponding author. In one-quadrant of each jaw, the extraction socket was preserved by immediate placement of LPRF as the experimental group, while the other side served as the control group for secondary healing.
Preparation of leukocyte platelet-rich fibrin
The protocol for LPRF preparation was simple and included the collection of whole venous blood from the brachial vein using a 10 mL syringe. The collected blood was transferred into two sterile vacutainer tubes (9 mL) without anticoagulant and were placed symmetrically into the centrifuge device. The intraspin tubes were immediately centrifuged (PCO 2 Process) at 2700 rpm for 12 min, after which, three layers were formed: red blood cells at the bottom, upper straw-colored cellular plasma, and the middle fraction containing the fibrin clot and platelets. The upper straw-colored layer was discarded, and the middle fraction was collected, 2 mm below the lower dividing line, which was LPRF. Fibrinogen which is initially concentrated in the upper part of the tube is combined with the circulating thrombin following centrifugation to form fibrin. A fibrin clot is then formed in the middle of the tube, right between the red corpuscles at the bottom and acellular plasma at the top. Platelets are trapped massively in the fibrin mesh [ Figure 1a and b].
The central part includes platelets trapped massively in the fibrin mesh. The success of this technique entirely depends on the time interval between blood collection and its centrifugation, which should be minimized. The blood sample without anticoagulant starts to coagulate almost immediately upon contact with the glass and decreases the required centrifugation time to concentrate fibrinogen. Adherence to the correct preparation protocol and quick handling are critical to obtain clinically usable LPRF clot charged with serum and platelets. Resistant autologous fibrin membranes may be available by driving out the fluids trapped in the fibrin matrix.
Orthodontic tooth movement
Within the scope of orthodontic treatment with fixed appliances (ROTH American Orthodontics Master/Mini-Series 0.022-inch slot), patients requiring extraction of their first premolars according to their orthodontic treatment plan after the leveling phase of treatment underwent augmentation of extraction socket with LPRF unilaterally immediately after extraction. Extraction of first premolars was performed a traumatically on both sides. On one side of each jaw, the extraction socket was preserved by immediate placement of LPRF in the extraction socket as the experimental group and the other sides served as the control for secondary healing. The LPRF plugs were placed gently into the socket, and the sockets were sutured using 4-0 Vicryl sutures (Ethicon). The teeth adjacent to the defect were then pulled together by a NiTi closed-coil spring (Ormco®, Orange, California, USA) with constant level of force. A piece of 0.016 × 0.022-inch stainless steel wire was used as the main archwire. The sites were examined weekly for any appliance dislodgment. The treatment was considered finished when the amount of OTM was considered clinically enough based on the clinical appraisal of individual pretreatment crowding and proposed treatment plan.
The amount of OTM was measured by comparing the change in horizontal linear distance between the mid-marginal ridges of the adjacent teeth on a regular Figure 2a and b]. If this distance decreases more in experimental side, it means that the teeth moved faster than control side.
Statistical analysis
Statistical analysis was performed using SPSS 18 (SPSS Inc., PASW statistics for windows,Version 18.1. ChicGO). In this split-mouth clinical trial, descriptive statistics, including the mean and SD of OTM in each group, were measured at eight different time points. The independent sample t-test was used to evaluate the equality of means in both experimental and control group. The random effect model was used for the comparison between the experimental and control groups, and variables, which could be considered as personal differences, were entered into the model using a split mouth design.
RESULTS
Thirty extraction sockets of eight patients (five males, three females, mean age of 17.37 years and SD of 12.48 years, and range 12-25 years) were assessed in this study. All patients completed the follow-up period. In seven patients, both maxillary and mandibular arches and in one patient only the mandibular arch were assessed. Table 1 shows the mean and SD of tooth movement in the control and experimental groups.
In all eight time points, the mean linear measurements between mid-marginal ridges of teeth adjacent to extraction sites were less in experimental groups compared to control. This distance decreased more in experimental side which means that the teeth moved faster than control side.
According to the random effect model, the experimental group (LPRF placed in the extraction socket) showed higher rate of OTM (P = 0.006). Figure 3 shows the pattern of tooth movement in the two groups. The graph shows the higher rate of OTM in the experimental group (P = 0.006). According to the random effect model, the teeth in the maxillary compared to mandibular arches in both the experimental and control group did not show any significant difference in the rate of OTM [P = 0.9 and P = 0.77, respectively, Table 2 ]. Table 2 shows the mean and SD of tooth movement (millimeters) in both the control and experimental groups in the maxillary and mandibular arches.
1: Comparison of the distance between marginal ridges of the teeth adjacent to sockets in millimeters between the experimental and control groups at each time point
DISCUSSION
The results of this study demonstrated that the distance between mid-marginal ridge points of crowns adjacent to extraction sites was less in experimental groups; therefore, it showed the possible positive efficacy of LPRF application in the extraction socket for acceleration of OTM including anchorage loss of posterior teeth. It means that anterior and posterior teeth adjacent to extraction sites moved faster toward each other in experimental groups. To the best of our knowledge, this is the first pilot study aiming to evaluate the efficacy of LPRF for acceleration of OTM in humans. To date, many surgically assisted approaches such as periodontally accelerated osteogenic orthodontics, corticotomy, and micro-osteoperforation with and without using PRP/LPRF have been developed to decrease the treatment time of fixed orthodontic patients. These approaches are all based on the regional acceleratory phenomenon. [27] [28] [29] [30] [31] Researchers tried to shift the invasive surgically assisted techniques to more conservative approaches including micro-osteoperforation, [31] piezopuncture, [32] and very recently mini-implant-facilitated micro-osteoperforation, [33] which eliminate the need for flaps, bone grafting, and suturing. However, these techniques may still traumatize the surrounding bone, undermine the periodontal support of teeth, and cause patient discomfort. [33] In addition, the intensity and extensity of their acceleratory effect depend on the intensity and extensity of the surgical insult, and therefore, conservative approaches might not be able to trigger a distinctive acceleratory effect on OTM. [34] To simulate the effects of surgical insult without actual surgical trauma, local injection of growth factors and cytokines, and recently, autologous PRP were introduced to stimulate alveolar bone remodeling. [25, 26, 35] PRP was first introduced to dentistry in 1998 to be combined with autogenous bone grafts to expedite bone maturation and result in higher bone density. [36] Hoaglin and Lines also conducted a study to evaluate the use of PRF for prevention of localized osteitis following lower third molar extraction. [6] This retrospective review demonstrated that preventative treatment of localized osteitis could be accomplished using a low cost, autogenous, soluble, biologic material, PRF, and that PRF enhanced third molar socket healing/clot retention and greatly decreased the clinical time required for postoperative management of localized osteitis. [6] Since then, many studies have evaluated the use of LPRF and PRF to facilitate implant placement and periapical surgeries, [37, 38] revascularization procedures, [39] perforation repair, and also bone regeneration in oral and maxillofacial region. [38] Considering the efficiency of PRP for healing of the alveolar socket after tooth extraction, there are controversies regarding its effect on postoperative pain, swelling, bleeding, and postoperative discomfort. [13, 40, 41] Radiographic examinations revealed an early and significant increased radiographic density at the PRP-treated sockets in comparison to the ipsilateral not PRP treated sites, [42, 43] demonstrating the effect of PRP on early phase of bone healing. However, in a prospective split-mouth study conducted by Arenaz-Bua et al., this acceleration in bone formation was not reported to last for more than 6 months. [41] On the other hand, considering the inhibitory effect of high concentration of PRP on bone cell division and bone density, a submucosal injection of PRP for acceleration of OTM was reported by Liou in 2016. [24] This study reported dose-dependent application of PRP for acceleration of tooth movement and for alveolar bone loss at the pressure side of en masse anterior retraction. However, submucosal injection of PRP is superior to other surgically assisted methods since it is a noninvasive and clinically feasible method. [24] In this technique, PRP is injected through the attached gingiva into the oral mucosa. The disadvantages of this technique include the necessity of administration of local anesthesia before injection for pain control, probability of PRP leakage during injection, and also the possibility of postinjection pain, discomfort, and mucosal swelling. In this study, 15% of patients reported severe postinjection pain, which was correlated with the PRP concentration level. [24] On the other hand, in orthodontic patients with extraction treatment plan, LPRF/PRP can be placed in the extraction sockets and there would be no need for its submucosal injection. However, controversies exist regarding the potential benefit of each procedure and further studies are needed to fully clarify the advantages of each method of delivery in extraction patients.
In vitro and in vivo studies have shown that the release of growth and healing factors peaks at around 7 days after buccal vestibular mucosal injection in rat models. However, this acceleratory effect was transient and seemed to decrease over the next 2-3 weeks. [15, 25] In a study by Güleç et al., on rat models, the difference in the amount of tooth movement between the experimental (high concentration PRP) and control group was significant at 7, 14, and 21 days. This result was in accordance with our study, in which the total amount of tooth movement in the experimental group was significantly higher at T1 (2 weeks = 14 days) and T2 (4 weeks = 28 days). However, in the study by Güleç et al., the study duration was limited to 21 days after buccal vestibular injection, and long-term effects were not evaluated in their study. [25] In a study by Liou on humans, it was stated that the clinical effect of a single submucosal injection of PRP could last for 5-6 months clinically. The fastest rate of acceleration was reported to be during the 2 nd -4 th month after the injection. [24] This result was in accordance with our study, in which the total amount of tooth movement in the experimental group was significantly higher at T1 (2 weeks = 14 days) and T2 (4 weeks = 28 days). In addition, based on this transient effect, they suggested a multi-PRP injection protocol based on the clinical objective including a single injection of PRP at the beginning of treatment for the purpose of alignment and leveling and another booster injection at 6 months after the first injection for the purpose of anterior retraction or posterior protraction. [24] One limitation of this study was lack of precise evaluation of whole blood and LPRF content and concentration of growth factors in each patient. Liou assessed the platelet count in 1 mL of the collected blood sample and final PRP sample. [24] In a recent study by Güleç et al., in 2017 , the rate of OTM was evaluated in rats histomorphometrically after submucosal injection of high and moderate concentrations of PRP. [25] They demonstrated that both high and moderate concentrations of PRP had a transient acceleratory effect on OTM in rats. This result was in contrast to the previous studies that reported the inhibitory effect of PRP on bone metabolism only in high concentrations of PRP. [44] The authors discussed that the reason may be the presence of mechanical force (dynamic loading) in contrast to static loading in the reported study. [25] Since PRP has a concentration-dependent effect on bone turnover [44] and also OTM, [25] it may be stated that different LPRF concentrations may also have different effects on bone turnover and OTM. [25] However, the split-mouth design of this study aimed to compensate for these possible interpersonal variations. Nevertheless, for future studies, it is highly recommended to determine the concentrations of platelets and leucocytes in the whole blood and LPRF samples by the use of ELISA before their application.
LPRF, similar to PRP products, is a mixture of various growth factors, cytokines, and enzymes, which may have overlapping biological effects and the exact mechanism of action of each ingredient is still unclear. [45] Many of these elements might demonstrate anti-inflammatory effects, responsible for the increased tissue healing capacity, and at the same time, many cytokines such as tissue necrosis factors might aggravate the inflammatory response and lead to accelerated tooth movement. [46] As stated in PRP studies, LPRF can also promote both inflammatory and anti-inflammatory responses and their exact effect could be mainly related to the timing of release, concentration, and content of its growth factors. [47] Considering the lack of available evidence on the effect of LPRF on the rate of tooth movement in humans, our result is not comparable to the findings of other studies in this field. The major limitation of this study was limited sample size and the relatively negligible observed clinical effect on acceleration of OTM.
A major strength of this study was that it showed the possibility of application of autologous blood-derived LPRF in humans compared to allogenic PRP application in rat models. Therefore, the observed result could not be attributed to immune reaction to the allogenic PRP injection. [25, 45] However, the inconvenience related to the need for venipuncture and blood-drawing procedure for preparation of LPRF should be considered before clinical application of this method. Furthermore, more randomized clinical trials are recommended.
CONCLUSION
More decrease in horizontal linear measurement between the mid-marginal ridges of teeth in experimental groups than control groups means that application of LPRF may accelerate OTM, particularly in cases with extraction treatment plan.
